|Conferences \ Past Conferences \ CRO/Sponsor Summit on Data Integrity in Clinical Research|
OverviewEnsuring integrity of the data generated for regulatory submissions is a major challenge today for both the CROs as well as the Sponsors. Where on one hand, computerization, automation and LIMS have helped in data management, on the other hand, it has also made data alterations much easier. Therefore, for regulatory success both the CRO conducting the study and the Sponsors have to play a pivotal role in ensuring Data Integrity.
SELECTBIO, for the first time in India, will bring both CROs and Sponsors at a single platform at "CRO/Sponsors Summit on Data Integrity in Clinical Research" which is scheduled to be held on July 21-22, 2016 in Hotel Radisson HITEC City, Hyderabad, India.
The theme for the deliberations will be "Best Data Practices for Patient Safety & Regulatory Success".This event will address various issues and challenges faced as well as best data practices followed by CROs and Sponsors for regulatory success in conducting Bio- equivalence studies. This event will also provide a platform for CROs to showcase their capabilities and help the sponsors to evaluate CROs for future business propositions.
Running alongside the conference will be an Exhibition covering the latest technological advances within the related fields. We look forward to welcoming you at the "CRO/Sponsor Summit on Data Integrity in Clinical Research" and Exhibition and hope that the days will be both informative and enjoyable.
President, Vice-President, Director, Managers and Scientist from CRO or Pharmaceutical Company from the following departments.
Sponsor/Pharma Organizations - Formulation Development, Regulatory Affairs, Analytical Development, Quality Control, Quality Assurance, Investigator Site Management, Outsourcing Management, Auditors
CRO/Clinical Trials Organizations - Clinical Research and Development, Analytical Method Development, IT & Data management, Pharmacovigilance, Medical Affairs R&D and Strategic issues, Business Development